Filing Flows › Petmed Express (PETS) › Q4 FY26
Petmed Express (PETS) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Jun 2, 2026
Petmed Express (PETS) reported revenue of $42.8M for the fourth quarter fiscal 2026 (Q4 FY26), -16% from a year earlier and +5% from the quarter before. Operating margin was -13.3%, net loss $4.1M (9.5% of revenue).
Petmed Express, Q4 FY26: revenue $42.8M (-16% year over year), operating margin -13.3%, net loss $4.1M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.8M | +5% | -16% |
| Operating profit | −$5.7M | — | — |
| Net earnings | −$4.1M | — | — |
| Operating cash flow | −$4.7M | — | -168% |
What changed
Revenue was $42.8M in Q4 FY26, down 16% year over year and up 5% from the previous quarter.
Gross margin was 32.6%, up 2.6 points from Q4 FY25. Operating costs exceeded revenue by $5.7M, an operating margin of -13.3%. Operating expenses fell 7% while revenue fell 16%. The quarter ended with a net loss of $4.1M, narrower than the previous quarter's $10.6M loss. Non-operating items added $1.5M, -37% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$4.7M. Non-cash charges added back $2.4M of depreciation and amortization and $272K of share-based compensation. Working capital and other items used $3.4M. Capital expenditures of $720K exceeded it, leaving free cash flow of −$5.5M.
Questions
What was Petmed Express' revenue in the fourth quarter fiscal 2026?
Petmed Express (PETS) reported revenue of $42.8M for the fourth quarter fiscal 2026 (Q4 FY26), -16% from a year earlier and +5% from the quarter before.
Was Petmed Express profitable in the fourth quarter fiscal 2026?
Operating loss was $5.7M (-13.3% of revenue) and net loss $4.1M.
Source: Petmed Express 10-K on SEC EDGAR.